Paper · 24253063

Sister chromatid differential staining and NOR activity of BrdU-resistant sublines.

Yongshan Y and 2 others. Theor Appl Genet, 1985. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Sister chromatid differential staining and NOR activity of BrdU-resistant sublines. Papers, record 24253063. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24253063

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Sister chromatid differential staining and NOR activity of BrdU-resistant sublines.; PubMed
Journal: Theor Appl Genet; PubMed
Year: 1985; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/24253063/; PubMed
DOI: https://doi.org/10.1007/bf00305986; PubMed
The journal: https://conductscience.org/library/journal-index/0145600; PubMed
Citations, by iCite: 3; iCite
Relative citation ratio, by iCite: 0.14; iCite
Revised in PubMed: 2021-10-21; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Yongshan Y	Y
2	Jin Q	Q
3	Xiahui X	X

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	1,170,504	Inhibition of myogenesis in a rat myoblast line by 5-bromodeoxyuridine.	Nature	1975	https://conductscience.org/library/papers/1170504	PubMed
2	6,023,374	DNA synthesis in 5-bromouracil tolerant HeLa cells. An autoradiographic study.	Exp Cell Res	1967	https://conductscience.org/library/papers/6023374	PubMed
3	9,732,750	Bromodeoxyuridine resistance in CHO cells occurs in three discrete steps.	Somatic Cell Genet	1982	https://conductscience.org/library/papers/9732750	PubMed
4	1,194,375	Non-mendelian segregation in hybrids between chinese hamster cells.	J Cell Physiol	1975	https://conductscience.org/library/papers/1194375	PubMed
5	4,477,047	Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine.	Cell	1974	https://conductscience.org/library/papers/4477047	PubMed
6	4,182,358	Isolation and characterization of thymidine transport mutants of Chinese hamster cells.	Exp Cell Res	1969	https://conductscience.org/library/papers/4182358	PubMed
7	4,560,692	Lac operator analogues: bromodeoxyuridine substitution in the lac operator affects the rate of dissociation of the lac repressor.	Proc Natl Acad Sci U S A	1972	https://conductscience.org/library/papers/4560692	PubMed
8	4,509,645	Bromodeoxyuridine dependence--a new mutation in mammalian cells.	Proc Natl Acad Sci U S A	1973	https://conductscience.org/library/papers/4509645	PubMed
9	4,633,171	Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.	J Cell Biol	1973	https://conductscience.org/library/papers/4633171	PubMed
11	623,754	Bromodeoxyuridine induction of deoxycytidine deaminase activity in a hamster cell line.	Biochim Biophys Acta	1978	https://conductscience.org/library/papers/623754	PubMed

1 to 10 of 14

See all 14 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMID	Title	Journal	Year	In Papers	Source
24,252,922	Cytogenetics and the major histocompatibility complex in a proliferating microcell-mediated hybrid clone.	Theor Appl Genet	1985	https://conductscience.org/library/papers/24252922	PubMed
24,241,572	Sister chromatid exchange in vivo, chromosomal characterization and NORs activity of leukemia cells during 5FU-treatments.	Theor Appl Genet	1987	https://conductscience.org/library/papers/24241572	PubMed
24,241,470	A cytogenetic characterization comparing a rat 6TG-resistant strain and 6TG-sensitive clones.	Theor Appl Genet	1987	https://conductscience.org/library/papers/24241470	PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24253063

GET https://conductscience.org/api/papers/v1/24253063/authors

API reference For AI assistants